This study aims to evaluate the imaging and clinical characteristics of adrenal metastases detected by [68Ga]Ga-PSMA PET/CT in prostate cancer patients and their correlation with key prognostic and histopathological markers, including Gleason scores and prostate-specific antigen (PSA) levels. This evidence concerns the gene FOLH1 and prostate cancer.